By: IPP Bureau
Last updated : October 13, 2026 9:42 am
Sun Pharma Board approves Rs. 10,000 crore NCD issuance
Sun Pharma Board approves Rs. 10,000 crore NCD issuance
The board of Sun Pharmaceutical Industries has officially approved the issuance of listed, unsecured non-convertible debentures (NCDs) worth Rs. 10,000 crore on a private placement basis. The capital raised through these structured tranches will optimize debt financing, bolster funding flexibility, and strengthen the pharmaceutical giant's core capital structure. Concurrently, non-executive independent director Gautam Doshi has stepped down from the company's board and related committees with immediate effect due to personal reasons.
Jubilant Pharmova approves Rs. 800 crore NCD Plan, seeks Rs. 2,500 crore debt limits
Jubilant Pharmova’s Board of Directors approved raising up to Rs. 800 crore via private placement through 80,000 non-convertible debentures (NCDs) of Rs. 1 lakh each, with a tenure of up to five years and a listing on the BSE Ltd.
The company is also seeking shareholder approval via a postal ballot to authorize up to Rs. 2,500 crore in total non-convertible debt securities outstanding at any time over a one-year period, which sets a ceiling rather than an immediate plan.
Fortis Healthcare to buy 26% stake In Clean Max Sau for Rs. 1.85 crore
Fortis Hospotel Limited, a subsidiary of Fortis Healthcare Limited, is buying a 26% stake in Clean Max Sau Private Limited for Rs. 1.85 crore. The deal involves acquiring 2,600 equity shares. It establishes a captive solar power arrangement to supply renewable energy to Fortis hospital facilities in Haryana.